Biosimilar Naming: FDA Asked Celltrion For Two Kinds Of Suffixes

 
• By Sue Sutter
  
Celltrion Headquarters
Celltrion's headquarters in Incheon, South Korea • Source: Celltrion
Pink Sheet Podcast

Learn what's happening at the US FDA. On the go.

Derrick Gingery and the team bring you a weekly "Drug Fix".

SpotifyApple PodcastsWebsite

More from Approvals

More from Product Reviews